KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 19, 2019 | $540,000 | Replaced |
| 1st Quarter - Amendment (this page) | Feb 19, 2021 | $660,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Legislation and regulation regarding the TRICARE program
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT New | — |
| FISH BROWN | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Taxation/Internal Revenue Code TAX
HR 748, Regarding the Cadillac tax on high cost employer provided health coverage. S. 80, to repeal the ACA health insurance tax. S. 172, to suspend for two years the ACA health insurance tax. HR 1398, to suspend the ACA health insurance tax for two years. S. 73 regarding the tax deduction for direct-to-consumer advertising
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT New | — |
| FISH BROWN | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Health Issues HCR
House Resolution 271, regarding the Justice Departments position in Texas v. United States HR 2062 & S. 1012, regarding 42 CFR Part 2 and confidentiality of certain health information HR 1884, with provisions to stabilize and strengthen the ACA and the nongroup insurance market. S. 470 regarding a Medicare buy-in option for individuals aged 50-64 S. 489 and HR 1277, regarding a Medicaid buy-in option S. 1129 to establish a single payer system based on Medicare for All. HR 1384 to establish a single payer health care system HR 1425 regarding reinsurance funding under the ACA HR 986 and S. 466 regarding Section 1332 state waiver guidance. HR 1010 regarding Short Term Limited Duration Insurance policies HR 1143 regarding Short Term Limited Duration Insurance policies HR 861 regarding surprise billing
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT New | — |
| FISH BROWN | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Medicare/Medicaid MMM
Legislation and regulation regarding the Medicare Advantage program HR 1839, regarding multiple Medicaid program changes, including the Medicaid Drug Rebate program. HR 2131 and S. 1114, to remove the Medicare benchmark cap. HR 1046 and S. 377, regarding Medicare Part D and requirements for HHS to negotiate drug prices HR 1781 Regarding MedPAC and MACPAC access to drug pricing and rebate data.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT New | — |
| FISH BROWN | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Pharmacy PHA
S. 61 and HR 478 regarding drug reimportation HR 965 and S 340, regarding abuse of Risk Evaluation and Mitigation Strategies (REMS) (CREATES Act.) HR 1499 regarding pay for delay in pharmaceutical markets HR 1503 regarding the FDA Orange Book HR 1520 regarding the FDA Purple Book HR 938 regarding generic drug approvals HR 2113 regarding drug pricing transparency
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID C BENNETT New | — |
| FISH BROWN | — |
| LAIRD D BURNETT | — |
| MARY PRUDENCE FITZPATRICK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.